3179 results for «380»

Filter By

3179 results

DCB in diffuse disease and small vessels: LIVE Educational Case from National University Heart Centre - Singapore

10 Oct 2025 – From AICT-AsiaPCR 2025

This educational session focuses on the application of drug-coated balloons (DCB) in the management of diffuse coronary disease and small vessel pathology. It guides clinicians in identifying suitable lesion subsets, optimizing lesion preparation using advanced imaging and physiological assessments, and determining the appropriate timing to transition...

Nightmare in cathlab

10 Oct 2025 – From AICT-AsiaPCR 2025

This session provides comprehensive guidance on managing complications encountered in the catheterization laboratory. It covers practical approaches to a range of procedural complications, strategies to prevent vascular site issues in emergency situations, and essential tips for managing coronary perforations, aneurysms, and complications during vessel preparation. The...

Best Abstracts of AICT-AsiaPCR 2025

10 Oct 2025 – From AICT-AsiaPCR 2025

This session showcases the best abstracts from AICT-AsiaPCR 2025, presenting cutting-edge research and clinical advancements in interventional cardiology. Topics include comparative evaluations of FFR techniques, predictive imaging markers, mechanical support in cardiogenic shock, novel diagnostic approaches, access strategies, TAVR outcomes, thrombectomy impact, STEMI management insights, and...

Expanding horizons in coronary calcified lesion management with intravascular lithotripsy

10 Oct 2025 – From AICT-AsiaPCR 2025

This session highlights advancements in managing coronary calcified lesions through intravascular lithotripsy using the Shockwave system. It discusses the unique mechanism of action for different calcium morphologies, reviews the latest clinical data, and addresses complex scenarios including diffuse lesions and challenging nodular or eccentric calcium deposits,...

Expanding horizons in coronary calcified lesion management with intravascular lithotripsy

New insights into mechanical circulatory support: Impella in CGS and protected PCI

10 Oct 2025 – From AICT-AsiaPCR 2025

This session provides in-depth insights into the evolving role of mechanical circulatory support, focusing on the use of Impella devices in cardiogenic shock (CGS) and protected high-risk percutaneous coronary interventions (PCI). Attendees will gain knowledge on patient selection criteria, the impact of the DanGer trial and...

Coronary interventions: access, devices and outcomes

10 Oct 2025 – From AICT-AsiaPCR 2025

This session delves into the latest developments in coronary interventions, highlighting advances in vascular access techniques, innovative devices, and clinical outcomes. Topics include endothelial progenitor cell dysfunction in restenosis, the efficacy of distal radial artery (DRA) puncture and sheathless catheters in underserved areas, the use of...

Coronary complications and rescue cases

11 Oct 2025 – From AICT-AsiaPCR 2025

This compelling session addresses complex coronary complications and rescue cases encountered in the cath lab. Through a series of challenging case studies, it highlights critical scenarios such as silent coronary artery threats, procedural nightmares, coronary perforations, and innovative rescue strategies that transform high-risk situations into successful...

Coronary complications and rescue cases

TAVI and aortic valve procedures

11 Oct 2025 – From AICT-AsiaPCR 2025

Focusing on transcatheter aortic valve interventions, this session covers a broad spectrum of complex cases including emergent TAV-in-SAV procedures, management of severely calcified bicuspid valves, zero-contrast TAVI techniques, and strategies for hostile anatomies. It provides valuable insights into procedural planning and follow-up to optimize patient care...

AICT-AsiaPCR 2025 Awards ceremony

11 Oct 2025 – From AICT-AsiaPCR 2025

The AICT-AsiaPCR 2025 Awards ceremony celebrates outstanding achievements and innovations in the field of interventional cardiology. This event recognizes the contributions of clinicians and researchers who have advanced cardiovascular care and highlights excellence across various domains within the specialty.

AICT-AsiaPCR 2025 Awards ceremony

AICT-AsiaPCR 2025 Closing ceremony

11 Oct 2025 – From AICT-AsiaPCR 2025

The AICT-AsiaPCR 2025 Closing ceremony marks the culmination of a comprehensive Course, reflecting on key scientific advancements, collaborative achievements, and the shared commitment to advancing cardiovascular medicine and patient care.

AICT-AsiaPCR 2025 Closing ceremony

AICT-AsiaPCR 2025 Opening ceremony

10 Oct 2025 – From AICT-AsiaPCR 2025

The AICT-AsiaPCR 2025 Opening Ceremony marked the commencement of the conference's comprehensive program, setting the stage for cutting-edge discussions and advancements in interventional cardiology across the Asia-Pacific region.

AICT-AsiaPCR 2025 Opening ceremony

Discover the new Evolut­™ PRO+ TAVI System

17 Jun 2021

New data from Optimize PRO interim analysis

From a design built on a proven platform1, the Evolut™ PRO+ system provides the performance and outcomes you need to help patients live life to the fullest.

Discover the new Evolut™ PRO+ TAVI System

PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease

30 Aug 2022

Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona

Elad Asher

Author

Elad Asher
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease

On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

05 Mar 2023

Mirvat Alasnag provides her take on this clinical trial presented by Yundai Chen at the American College of Cardiology Scientific Session (ACC.23/WCC).

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
On-site computed tomography-derived fractional flow reserve to guide the management of patients with stable coronary artery disease: The TARGET randomized trial

The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation

27 Aug 2023

Quantitative coronary angiography-guidance versus intravascular ultrasound-guidance for drug-eluting stent implantation (GUIDE-DES trial): A multicenter, non-inferiority, randomised-controlled trial

Nicola Ryan provides her take on the final results of GUIDE-DES which were presented by Taeoh Kim during the ESC 2023 congress in Amsterdam.

Note the assumptions in this article are based on the presentation...

Nicola Ryan

Author

Nicola Ryan
The GUIDE-DES Trial - QCA versus IVUS guidance for DES implantation

Transcatheter vs surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut Low Risk trial

05 Mar 2023

Luigi Biasco provides his take on the clinical trial presented by John K. Forrest from Yale University School of Medicine, New Haven, Connecticut, USA during the 2023 ACC/WCC annual congress held in New Orleans, Louisiana.

Luigi Biasco

Author

Luigi Biasco
Transcatheter versus surgical aortic valve replacement in aortic stenosis patients at low surgical risk: 3-year outcomes from the Evolut low risk Trial

NOTION-3 - Percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation

01 Sep 2024

Make the most of the insights from Jacob Thomsen Loenborg’s interview with Chiara De Biase and Ali Nazmi Calik’s article to capture the key takeaways from this trial, simultaneously published in the NEJM, presented at the ESC Congress 2024 in London.

Author

Chiara De Biase
Jacob Lønborg

Author

Jacob Thomsen Lonborg

Author

Ali Nazmi Calik
NOTION 3

Implantation of the Portico With FlexNav TAVI System in a patient with aortic stenosis, severe renal impairment, and diffuse iliac atherosclerosis

12 May 2020

Real-world case report illustrating the benefits of the Portico with FlexNav TAVI system.

Implantation of the Portico With FlexNav TAVI System in a patient with aortic stenosis, severe renal impairment, and diffuse iliac atherosclerosis

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase
The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]
Didn’t find what you were looking for?